Korean J Med.  2013 Mar;84(3):464-479. 10.3904/kjm.2013.84.3.464.

COPD Guideline Revised 2012: Contracted Version

• No authors listed

• KMID: 1833863
• DOI: http://doi.org/10.3904/kjm.2013.84.3.464

Abstract

COPD imposes significant morbidity and mortality in Korea. The Korean Academy of Tuberculosis and Respiratory Diseases (KATRD) revised the practice guideline of COPD in 2012. The revised guideline was developed not only with the agreement of the KATRD members but also with the input from the representatives of Korean Physician's Association and Health Insurance Review & Assessment Service. In the revised guideline, recommendations were developed by systematic reviews based on PICO (population, intervention, comparison, and outcome) and GRADE (The Grading of Recommendations Assessment Development and Evaluation). Patients aged over 40 with smoking history, dyspnea, cough, and phlegm should be suspected to have COPD. To confirm and diagnose COPD, pulmonary function test of spirometry is required. In addition to pulmonary function, dyspnea symptom and exacerbation frequency should be evaluated to classify COPD patients into three groups, A, B, and C. The guideline recommends for patients in group A an inhaled short-acting bronchodilator to control the symptoms; for patients in B, an inhaled long-acting anticholinergics or an inhaled long-acting beta2 agonist; for patients in C, an inhaled long-acting anticholinergics, an inhaled long-acting beta2 agonist, or a combination of inhaled corticosteroid and long-acting beta2 agonist (low level of evidence and strong recommendation).

Keyword

COPD; Clinical practice guideline

MeSH Terms

Aged
Cholinergic Antagonists
Contracts
Cough
Dyspnea
Humans
Insurance, Health
Korea
Pulmonary Disease, Chronic Obstructive
Respiratory Function Tests
Smoke
Smoking
Spirometry
Tuberculosis
Cholinergic Antagonists
Smoke